-
-
-
-
-
-
-
Xeris Biopharma Reports Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
Xeris Biopharma Reports First Quarter 2023 Financial Results
-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Tops Q3 EPS by 3c
-
-
-
-
-
-
-
Xeris Biopharma to Report First Quarter 2022 Financial Results on May 11, 2022
-
-
-
-
-
-
-
Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights
-
-
-
-
-
-
-
Xeris Pharmaceuticals Announces Leading Independent Proxy Advisory Firm, ISS, Recommends Xeris Stockholders Vote “FOR” the Transaction With Strongbridge Biopharma
-
-
-
-
-
-
-
Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases
-
976,651 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All